Pre-Therapy Prediction of Absorbed Dose in [ 177 Lu] Lu-PSMA-617 Therapy Using Radiomic Features from [ 68 Ga]Ga-PSMA-11 PET/CT (EANM 2026) - Sep 29, 2026 - Abstract #EP-1016; "Radiomics-based modeling from pre-therapy [68Ga]Ga-PSMA-11 PET/CT enables reliable prediction of OAR absorbed dose coefficients in [177Lu] Lu-PSMA-617 therapy, establishing a feasible pathway toward pre-treatment dosimetry and individualized therapy planning."
Castration-Resistant Prostate Cancer • Genito-urinary Cancer • Prostate Cancer • Solid Tumor
|
|
P. Geramifar 1; E. Yazdani 1, 2; I. Klyuzhin 1, 3; A. Dhalla 1; P. Esquinas 1, 4, 5; F. Farhadi 3; B. Saboury 3, 4; C. Uribe 1, 4, 5; A. Rahmim 1, 4, 5
|